Women are almost twice as likely to experience anxiety as men, according to a review of existing scientific literature, led by the University of Cambridge. The study also found that people from Western Europe and North America are more likely to suffer from anxiety than people from other cultures.
Paul Cartledge (Faculty of Classics) discusses what the ancient Greeks would think of our democracy.
Researchers have devised a new method for stacking microscopic marbles into regular layers, producing intriguing materials which scatter light into intense colours, and which change colour when twisted or stretched.
Flash floods, burst riverbanks, overflowing drains, contaminants leaching into waterways: some of the disruptive, damaging and hazardous consequences of having too much rain. But can cities be designed and adapted to live more flexibly with water – to treat it as friend rather than foe?
Geoffrey Edwards (Department of Politics and International Studies) discusses what motivates some people to support Brexit.
Michael Gaultois (Department of Chemistry), Joshua Conrad Jackson (University of North Carolina - Chapel Hill), Ian Mahar (Boston University), and Jaan Altosaar (Princeton University) discuss why much reporting on science is currently failing to resolve the trade-off between accessibility and accountability.
Heliconius butterflies have evolved bright yellow colours to deter predators, while peppered moths famously turned black to hide from birds. A new study reveals that the same gene causes both, raising fascinating questions about how evolution by natural selection occurs in these species.
The male and female brains have more in common than media reports often suggest, argues Julia Gottwald, a third year PhD student at the Department of Psychiatry. Writing in the student science magazine BlueSci, she explains what we understand about the similarities and differences in our brains and why this is an important area of research.
An approach that could reduce the chances of drugs failing during the later stages of clinical trials has been demonstrated by a collaboration between the University of Cambridge and pharmaceutical company GlaxoSmithKline (GSK).
Today, we commence a month-long focus on the future of cities. To begin, Doug Crawford-Brown, Robert Mair and Koen Steemers describe the challenges our future cities will face and how mitigation depends on the innovations we create and put in place today.
© 2025 University of Cambridge